Syschem (India) Ltd.
Snapshot View

View in App

Prices View details >>

52.00 +2.45 ▲4.9%

03 October 2022, 02:39:00 PM
Volume: 39,044

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.syschem.in
Market Cap 158.81 Cr.
Enterprise Value(EV) 152.70 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.16 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 323.44 Trailing Twelve Months Ending 2022-06
Industry PE 31.52 Trailing Twelve Months Ending 2022-06
Book Value / Share 5.58 Trailing Twelve Months Ending 2022-06
Price to Book Value 9.33 Calculated using Price: 52.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 3.05 Cr. 30,540,400 Shares
FaceValue 10
Company Profile
Syschem India was incorporated on December 31, 1993 as Anil Pesticides and obtained certificate of commencement of business on February 1, 1994. The company is promoted by Anil Nibber, Atul Nibber and Ajay Kumar Singla.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+4.94%
1 Week
+4.31%
1 Month
+8.90%
3 Month
+101.16%
6 Month
+339.93%
1 Year
+441.10%
2 Year
+665.83%
5 Year
+467.07%
10 Year
+309.45%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 4.37 -32.44 -25.21 -19.78 4.43 7.67 -17.24 -66.17 -26.16
Return on Capital Employed (%) 7.88 -10.60 -8.30 -6.68 2.68 5.51 -8.22 -29.75 -12.18
Return on Assets (%) 1.16 -7.41 -4.69 -3.41 0.69 1.30 -3.06 -8.28 -2.64

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 14 15 11 9 7 9 12 10 7 7
Non Curr. Liab. 22 22 20 19 13 12 11 12 26 23
Curr. Liab. 11 17 19 18 22 34 37 39 41 26
Minority Int.
Equity & Liab. 48 55 50 45 42 56 61 61 74 56
Non Curr. Assets 36 37 35 33 31 30 28 30 32 32
Curr. Assets 12 17 15 13 11 26 32 31 42 24
Misc. Exp. not W/O
Total Assets 48 55 50 45 42 56 61 61 74 56

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 18 11 4 13 67 93 77 68 59 62
Other Income 1 0 0 0 0 0 0 0
Total Income 20 11 4 13 67 93 77 69 59 63
Total Expenditure -14 -14 -5 -13 -63 -90 -77 -74 -58 -60
PBIDT 5 -3 -1 0 3 4 0 -5 1 3
Interest -3 -1 0 0 0 0 0 0 0 0
Depreciation -2 -2 -2 -2 -2 -2 -2 -2 -3 -3
Taxation 0 1 1 1 0 -1 0 2 0 0
Exceptional Items 0
PAT 1 -4 -2 -1 0 1 -2 -6 -2 0
Adjusted EPS 0 -2 -1 -1 0 0 -1 -3 -1 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 4 4 1 0 6 0 -2 3 4 1
Cash Fr. Inv. -13 -3 0 0 0 0 2 -4 -4 -1
Cash Fr. Finan. 10 -1 -2 -1 -7 0 0 0 0 0
Net Change 1 0 -1 0 0 0 0 0 0
Cash & Cash Eqvt 1 1 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 10.54 9.54 9.54 9.54 9.54 16.34 16.34 16.34 21.78
Public 89.46 90.46 90.46 90.46 90.46 83.66 83.66 83.66 78.22
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 20.20 19.47 19.47 19.47 19.47 10.51 10.51 0.00 0.00

Announcements View Details >>

Sat, 01 Oct 2022
Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- Ranjan Jain
Designation :- Managing Director / Whole Time Director
Wed, 28 Sep 2022
Closure of Trading Window
As per SEBI(Prohibition of Trading Window) 2015 Closure of Trading Window for the Quarter ended 30th September 2022
Mon, 19 Sep 2022
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
Syschem India Ltd has informed BSE regarding the details of Voting results of AGM under Regulation 44(3) of SEBI (LODR) Regulations 2015. Kindly Click here

Technical Scans View Details >>

Fri, 30 Sep 2022
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Entering 52 Week High Zone Close Entering 52 Week High Zone
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
High Increase 6 Months High Increase 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 227,696.89 948.05 -0.1%
Divi's Laboratories Ltd. 97,811.90 3,733.70 +0.8%
Cipla Ltd. 89,996.82 1,138.05 +2.1%
Dr. Reddy's Laboratories Ltd. 72,145.56 4,412.25 +1.8%
Apollo Hospitals Enterprise Ltd. 62,833.90 4,383.60 0.0%
Torrent Pharmaceuticals Ltd. 52,506.43 1,582.50 +1.4%
Abbott India Ltd. 40,438.70 18,769.25 -1.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.54 948.05 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,733.70 +0.8%
Cipla Ltd. Consolidated 2022-06 36.17 1,138.05 +2.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.12 4,412.25 +1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.12 4,383.60 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.55 1,582.50 +1.4%
Abbott India Ltd. Standalone 2022-06 50.01 18,769.25 -1.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.54 948.05 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,733.70 +0.8%
Cipla Ltd. Consolidated 2022-06 4.19 1,138.05 +2.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.56 4,412.25 +1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.57 4,383.60 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.21 1,582.50 +1.4%
Abbott India Ltd. Standalone 2022-06 13.56 18,769.25 -1.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 948.05 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,733.70 +0.8%
Cipla Ltd. Consolidated 2022-03 0.04 1,138.05 +2.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,412.25 +1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,383.60 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,582.50 +1.4%
Abbott India Ltd. Standalone 2022-03 0.00 18,769.25 -1.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 948.05 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,733.70 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,138.05 +2.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,412.25 +1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,383.60 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,582.50 +1.4%
Abbott India Ltd. Standalone 2022-03 29.95 18,769.25 -1.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 948.05 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,733.70 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,138.05 +2.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,412.25 +1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,383.60 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,582.50 +1.4%
Abbott India Ltd. Standalone 2022-03 29.95 18,769.25 -1.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 948.05 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,733.70 +0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,138.05 +2.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,412.25 +1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,383.60 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,582.50 +1.4%
Abbott India Ltd. Standalone 2022-03 4,919.27 18,769.25 -1.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 948.05 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,733.70 +0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,138.05 +2.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,412.25 +1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,383.60 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,582.50 +1.4%
Abbott India Ltd. Standalone 2022-03 798.70 18,769.25 -1.9%

FAQ's On Syschem (India) Ltd.

What is Syschem (India) share price?
Can I buy Syschem (India) shares now?
What is the Market Cap of Syschem (India)?
What are the key metrics to analyse Syschem (India)?
What is the 52 Week High and Low of Syschem (India)?
What is the trend of Syschem (India) share price?